Application of Convergent Science and Technology toward Ocular Disease Treatment.

convergent science drug delivery nanotechnology ocular disease smart contact lens

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
16 Mar 2023
Historique:
received: 22 01 2023
revised: 07 03 2023
accepted: 10 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods for treating ocular disease has attracted lots of attention. This is especially due to the ineffectiveness of the conventional therapeutic method to deliver drugs into the interior parts of the eye, and the also presence of barriers such as tear film, blood-ocular, and blood-retina barriers. Recently, some novel techniques, such as different types of contact lenses, micro and nanoneedles and in situ gels, have been introduced which can overcome the previously mentioned barriers. These novel techniques could enhance the bioavailability of therapeutic components inside the eyes, deliver them to the posterior side of the eyes, release them in a controlled manner, and reduce the side effects of previous methods (such as eye drops). Accordingly, this review paper aims to summarize some of the evidence on the effectiveness of these new techniques for treating ocular disease, their preclinical and clinical progression, current limitations, and future perspectives.

Identifiants

pubmed: 36986546
pii: ph16030445
doi: 10.3390/ph16030445
pmc: PMC10053244
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Asian J Pharm Sci. 2020 Sep;15(5):617-636
pubmed: 33193864
Int J Nanomedicine. 2013;8:495-503
pubmed: 23439842
Life Sci. 2020 Feb 15;243:117303
pubmed: 31953158
Ther Deliv. 2017 Mar;8(5):313-330
pubmed: 28361605
J Control Release. 2015 Sep 10;213:168-174
pubmed: 26184051
Vaccines (Basel). 2022 Nov 17;10(11):
pubmed: 36423041
J Nanosci Nanotechnol. 2016 Jun;16(6):5480-8
pubmed: 27427587
Arch Soc Esp Oftalmol (Engl Ed). 2020 Jan;95(1):24-33
pubmed: 31420118
Eur J Pharm Biopharm. 2021 Feb;159:44-76
pubmed: 33359666
Sci Adv. 2019 Mar 20;5(3):eaav1281
pubmed: 30906864
Biomed Pharmacother. 2018 Nov;107:1056-1063
pubmed: 30257317
Acta Pharm Sin B. 2017 May;7(3):281-291
pubmed: 28540165
Nat Commun. 2022 Nov 10;13(1):6801
pubmed: 36357417
Int J Pharm. 2020 Mar 15;577:119035
pubmed: 31953080
Front Pharmacol. 2019 Nov 29;10:1363
pubmed: 31849644
Int J Mol Sci. 2019 Sep 25;20(19):
pubmed: 31557880
Toxicol Res (Camb). 2020 Aug 25;9(4):578-587
pubmed: 32905229
Dose Response. 2019 Oct 14;17(4):1559325819878585
pubmed: 31662709
J Biomater Sci Polym Ed. 2020 Aug;31(12):1566-1579
pubmed: 32354260
Invest Ophthalmol Vis Sci. 2013 Apr 03;54(4):2483-92
pubmed: 23532526
Int J Pharm. 2019 Oct 5;569:118573
pubmed: 31356955
J Control Release. 2023 Feb;354:465-488
pubmed: 36642250
Int J Pharm. 2021 Oct 25;608:121090
pubmed: 34530102
Int J Pharm. 2019 May 1;562:1-10
pubmed: 30878586
RSC Adv. 2019 May 28;9(29):16578-16585
pubmed: 35516366
Adv Mater. 2021 Jun;33(24):e2007663
pubmed: 33956371
J Pharm Pharmacol. 2022 Oct 10;74(10):1406-1426
pubmed: 36215694
Int J Pharm. 2019 Dec 15;572:118808
pubmed: 31678387
Int J Nanomedicine. 2019 Apr 08;14:2515-2531
pubmed: 31040672
JAMA Ophthalmol. 2013 Jun;131(6):783-6
pubmed: 23764703
J Control Release. 2021 Jul 10;335:158-177
pubmed: 33984344
Ophthalmology. 2020 Dec;127(12):1627-1641
pubmed: 32544560
Carbohydr Polym. 2022 Sep 1;291:119552
pubmed: 35698331
Pharmaceutics. 2022 Oct 28;14(11):
pubmed: 36365142
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3222-30
pubmed: 27327581
Int J Pharm. 2021 Nov 20;609:121188
pubmed: 34655707
Adv Drug Deliv Rev. 2018 Feb 15;126:67-95
pubmed: 29339145
J Control Release. 2017 Feb 28;248:96-116
pubmed: 28087407
Int J Pharm. 2020 Feb 25;576:119020
pubmed: 31935477
Eur J Pharm Biopharm. 2021 Aug;165:306-318
pubmed: 34048879
Int J Mol Sci. 2020 Dec 04;21(23):
pubmed: 33291796
Expert Rev Med Devices. 2020 May;17(5):443-460
pubmed: 32176853
Bioeng Transl Med. 2022 Apr 16;7(3):e10323
pubmed: 36176623
Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110767
pubmed: 32279789
RSC Adv. 2020 Jul 24;10(46):27835-27855
pubmed: 35516960
Nanomaterials (Basel). 2021 Sep 07;11(9):
pubmed: 34578644
J Control Release. 2022 Aug;348:186-205
pubmed: 35662577
J Control Release. 2019 Jul 10;305:18-28
pubmed: 31103677
Transl Vis Sci Technol. 2020 Mar 09;9(4):1
pubmed: 32818089
Adv Healthc Mater. 2022 Jun;11(12):e2102599
pubmed: 35192734
J Biomater Appl. 2022 Aug;37(2):333-343
pubmed: 35482359
Biomater Adv. 2022 Jun;137:212767
pubmed: 35929230
RSC Adv. 2021 Aug 31;11(46):29065-29072
pubmed: 35478587
J Pharm Sci. 2007 Sep;96(9):2350-63
pubmed: 17541976
ACS Nano. 2015 Feb 24;9(2):1749-58
pubmed: 25585134
J Biomed Mater Res A. 2007 Jul;82(1):41-51
pubmed: 17265438
Nanomedicine. 2010 Feb;6(1):9-24
pubmed: 19447208
Cornea. 2019 Jun;38(6):713-717
pubmed: 30908338
ACS Sens. 2022 Oct 28;7(10):3014-3022
pubmed: 36260093
Acta Biomater. 2018 Oct 15;80:48-57
pubmed: 30267886
Life Sci. 2021 Nov 1;284:119877
pubmed: 34384832
Int J Mol Sci. 2022 Aug 01;23(15):
pubmed: 35955664
Int J Pharm. 2022 Sep 25;625:122094
pubmed: 35952803
Lancet Neurol. 2005 Feb;4(2):111-21
pubmed: 15664543
J Mater Chem B. 2022 Aug 17;10(32):6059-6077
pubmed: 35916308
Anal Chem. 2000 Jan 15;72(2):367-75
pubmed: 10658332
Bioact Mater. 2021 Jul 28;9:77-91
pubmed: 34820557
Biosensors (Basel). 2021 Aug 25;11(9):
pubmed: 34562886
Nanomaterials (Basel). 2021 Jan 12;11(1):
pubmed: 33445545
Int J Mol Sci. 2021 Nov 16;22(22):
pubmed: 34830247
Sci Rep. 2018 Jan 22;8(1):1360
pubmed: 29358594
Polymers (Basel). 2021 Mar 30;13(7):
pubmed: 33808363
Small. 2022 Jan;18(4):e2104657
pubmed: 35083856
Drug Deliv Transl Res. 2021 Jun;11(3):866-893
pubmed: 32901367
Curr Opin Ophthalmol. 2004 Aug;15(4):305-10
pubmed: 15232469
Pharmaceuticals (Basel). 2020 Oct 29;13(11):
pubmed: 33138064
Int J Biol Macromol. 2020 May 1;150:559-572
pubmed: 32057864
Biomater Sci. 2020 Sep 15;8(18):5196-5209
pubmed: 32840522
Mol Pharm. 2016 Oct 3;13(10):3468-3477
pubmed: 27571217
Cont Lens Anterior Eye. 2021 Dec;44(6):101487
pubmed: 34353748
J Nanobiotechnology. 2022 Aug 2;20(1):361
pubmed: 35918688
J Pharm Sci. 2013 Feb;102(2):627-37
pubmed: 23203974
J Basic Clin Pharm. 2011 Mar;2(2):87-101
pubmed: 24826007
Nat Commun. 2018 Nov 6;9(1):4433
pubmed: 30401883
Nanomedicine. 2020 Oct;29:102260
pubmed: 32629041
Int J Pharm. 2021 Jun 1;602:120623
pubmed: 33892058
Pharmaceutics. 2020 Jun 19;12(6):
pubmed: 32575392
Sci Adv. 2020 Apr 24;6(17):eaba3252
pubmed: 32426469
Invest Ophthalmol Vis Sci. 2014 Sep 11;55(11):7376-86
pubmed: 25212779
Chem Rev. 2021 Sep 22;121(18):11336-11384
pubmed: 33507740
Int J Pharm. 2022 Jul 25;623:121938
pubmed: 35728716
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4038-43
pubmed: 17724185
Nano Today. 2021 Feb;36:
pubmed: 33425002
Drug Discov Today. 2019 Aug;24(8):1679-1684
pubmed: 31175955
Acta Biomater. 2020 Oct 1;115:60-74
pubmed: 32853799
Int J Pharm. 2023 Jan 5;630:122444
pubmed: 36503848
Pharm Dev Technol. 2022 Feb;27(2):127-133
pubmed: 34704874
Biomaterials. 2020 Jun;243:119961
pubmed: 32171102
Biomedicines. 2021 Sep 12;9(9):
pubmed: 34572389
Eye (Lond). 2021 Apr;35(4):1084-1101
pubmed: 33414529
Int J Pharm. 2022 Apr 5;617:121615
pubmed: 35217072
Drug Deliv Transl Res. 2020 Aug;10(4):919-944
pubmed: 32270439
Int J Pharm. 2022 Nov 5;627:122195
pubmed: 36115466
J Biomed Mater Res B Appl Biomater. 2017 Oct;105(7):1799-1807
pubmed: 27192551
AAPS PharmSciTech. 2019 Jun 3;20(5):210
pubmed: 31161269
Nat Commun. 2022 May 17;13(1):2556
pubmed: 35581184
Colloids Surf B Biointerfaces. 2021 Oct;206:111957
pubmed: 34216853
Ocul Surf. 2006 Jul;4(3):146-54
pubmed: 16900270
Acta Biomater. 2019 Mar 1;86:350-362
pubmed: 30625414
Indian J Ophthalmol. 2020 Dec;68(12):2831-2834
pubmed: 33229658
Adv Sci (Weinh). 2022 Mar;9(9):e2103254
pubmed: 35092362
Colloids Surf B Biointerfaces. 2021 Jan;197:111396
pubmed: 33075661
AAPS PharmSciTech. 2019 Dec 5;21(1):12
pubmed: 31807980
ACS Nano. 2020 Feb 25;14(2):2483-2496
pubmed: 31935066
Sci Adv. 2022 Apr;8(13):eabn1772
pubmed: 35353558
J Cataract Refract Surg. 2022 Jul 1;48(7):751-752
pubmed: 35749068
Adv Sci (Weinh). 2019 Jun 20;6(16):1802289
pubmed: 31453052
Int J Nanomedicine. 2021 Nov 30;16:7847-7857
pubmed: 34876813
J Mater Chem B. 2020 Nov 18;8(44):10087-10092
pubmed: 32844863
J Control Release. 2013 Jan 10;165(1):82-9
pubmed: 23123188
Int J Mol Sci. 2018 Sep 19;19(9):
pubmed: 30235809
Int J Pharm. 2021 Apr 15;599:120455
pubmed: 33676993
Life Sci. 2019 Nov 15;237:116907
pubmed: 31606378
Ther Adv Ophthalmol. 2022 Jun 27;14:25158414221106682
pubmed: 35782482
Pharmaceutics. 2020 Nov 17;12(11):
pubmed: 33212921
Biomaterials. 2019 Mar;197:345-367
pubmed: 30690421
Biomaterials. 2018 Mar;157:98-106
pubmed: 29258013
J Control Release. 2018 Jul 10;281:97-118
pubmed: 29782944
Mol Ther. 2009 Apr;17(4):593-9
pubmed: 19174761
J Biomater Sci Polym Ed. 2020 Mar;31(4):549-560
pubmed: 31902299
Eur J Pharm Biopharm. 2021 Apr;161:80-99
pubmed: 33607239
Int J Pharm. 2020 Jun 15;583:119402
pubmed: 32387308
Carbohydr Polym. 2022 Nov 1;295:119787
pubmed: 35989028
J Mater Chem B. 2022 Apr 13;10(15):2912-2925
pubmed: 35297911
Rom J Ophthalmol. 2015 Oct-Dec;59(4):235-242
pubmed: 29450313
Adv Healthc Mater. 2021 Jul;10(13):e2100100
pubmed: 34050621
Exp Eye Res. 2023 Jan;226:109339
pubmed: 36470431
Int J Mol Sci. 2019 Jun 12;20(12):
pubmed: 31212734
Adv Healthc Mater. 2019 May;8(10):e1801390
pubmed: 30938941
Expert Opin Drug Deliv. 2006 Mar;3(2):275-87
pubmed: 16506953

Auteurs

Ayça Bal-Öztürk (A)

Department of Stem Cell and Tissue Engineering, Institute of Health Sciences, Istinye University, Istanbul 34396, Türkiye.
Department of Analytical Chemistry, Faculty of Pharmacy, Istinye University, Istanbul 34396, Türkiye.

Ece Özcan-Bülbül (E)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Istinye University, Istanbul 34396, Türkiye.

Hazal Ezgi Gültekin (HE)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir 35620, Türkiye.

Berivan Cecen (B)

Department of Mechanical Engineering, Rowan University, Glassboro, NJ 08028, USA.
Department of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA.

Ebru Demir (E)

Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Türkiye.
Molecular Biology, Genetics and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye.

Atefeh Zarepour (A)

Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul 34396, Türkiye.

Sibel Cetinel (S)

Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Türkiye.
Molecular Biology, Genetics and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Türkiye.

Ali Zarrabi (A)

Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul 34396, Türkiye.

Classifications MeSH